World Leaders in Genomics
The Medical Genomics Board is made up of world leaders in genomics with multidisciplinary expertise with scientists and qualified genomics professionals, including geneticists, molecular biochemists and clinical experts in pharmacogenomics, nutrigenomics and oncogenomics, prenatal, neonatal and pediatric rare diseases.
Our goal
The goal is to pursue the path of personalized therapeutic maps through the organization of a clear reporting system despite the great complexity of the data deriving from the whole genome sequencing in NGS. It is Dante’s intention to establish more of these regional Medical Genomics Boards around the world to bring genomics to the forefront of precision medicine in healthcare, taking into account the regional and cultural considerations of each area.
Bringing expertise on board
The members of the Board all come from medical and academia backgrounds, including doctors, pharmacists and biologists. These experts in Omic sciences were chosen to cover all therapeutic areas, from oncogenomics to pharmacogenomics.
Our board
-
Giuseppe Novelli
Scientific Director - Scholar of multifactorial genetic diseases
-
Giovanni Pellacani
Professor in dermatology at the Sapienza University of Rome
-
Laura di Renzo
From the Tor Vergata Polyclinic in Rome where she deals with nutrigenetics and nutrigenomics
-
Sergio Bernardini
Professor in clinical biochemistry and molecular biology
-
Antonio Novelli
Who deals with genomics in prenatal diagnosis at the Bambino Gesù Children's Hospital in Rome
-
Salvatore Minisola
Professor in Internal Medicine at the Sapienza University of Rome
-
Camilla Nero
Expert on oncogenomics from the Catholic University of Rome
